
Inhibitors of hepatitis C virus polymerase: Synthesis and characterization of novel 2-oxy-6-fluoro-N-((S)-1-hydroxy-3-phenylpropan-2-yl)-benzamides
Keywords: HCV NS5B polymerase; Hepatitis C virus; Palm site inhibitors; Replicon; Antiviral; ALIS: automated ligand identification system; Structure based drug design (SBDD)